HighTower Advisors
INSM icon

HighTower Advisors’s Insmed INSM Stock Holding History

HighTower Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
4,261
+364
+9% +$44.1K ﹤0.01% 2828
2026
Q1 		$637K Buy
3,897
+861
+28% +$132K ﹤0.01% 2518
2025
Q4 		$528K Buy
3,036
+349
+13% +$63.7K ﹤0.01% 2572
2025
Q3 		$387K Buy
2,687
+535
+25% +$65.5K ﹤0.01% 2824
2025
Q2 		$217K Buy
+2,152
New +$165K ﹤0.01% 3212

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

HighTower Advisors's INSM Position: Q2 2026 in Review

HighTower Advisors increased its Insmed (INSM) stake by 9.3% in Q2 2026, buying an estimated $44.1K and bringing the position to 4,261 shares worth $454K. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

HighTower Advisors first reported a position in INSM in Q2 2025 and has held it in 5 quarters since. The position peaked at $637K in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • HighTower Advisors held 4,261 shares of Insmed worth $454K as of Q2 2026.
  • HighTower Advisors bought 364 Insmed shares in Q2 2026, an estimated $44.1K.
  • Insmed made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2828 holding.
  • HighTower Advisors first reported a position in Insmed in Q2 2025 and has held it in 5 quarters since.
  • HighTower Advisors's Insmed position peaked at $637K in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.